Aligos Therapeutics, Inc. (ALGS)
2.15
-0.42
(-16.34%)
USD |
NASDAQ |
Nov 11, 16:00
2.09
-0.06
(-2.79%)
After-Hours: 19:59
Aligos Therapeutics Total Assets (Quarterly) : 47.19M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 47.19M |
| June 30, 2026 | 66.33M |
| March 31, 2026 | 64.56M |
| December 31, 2025 | 89.58M |
| September 30, 2025 | 109.76M |
| June 30, 2025 | 134.71M |
| March 31, 2025 | 150.70M |
| December 31, 2024 | 71.85M |
| September 30, 2024 | 88.43M |
| June 30, 2024 | 108.81M |
| March 31, 2024 | 127.90M |
| December 31, 2023 | 153.90M |
| September 30, 2023 | 85.85M |
| Date | Value |
|---|---|
| June 30, 2023 | 106.13M |
| March 31, 2023 | 121.74M |
| December 31, 2022 | 149.86M |
| September 30, 2022 | 164.07M |
| June 30, 2022 | 182.52M |
| March 31, 2022 | 210.47M |
| December 31, 2021 | 239.14M |
| September 30, 2021 | 263.07M |
| June 30, 2021 | 211.88M |
| March 31, 2021 | 234.54M |
| December 31, 2020 | 268.97M |
| September 30, 2020 | 92.18M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 245.55M |
| Amgen, Inc. | 96.05B |
| Anika Therapeutics, Inc. | 189.60M |
| BioCryst Pharmaceuticals, Inc. | 591.07M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 35.88M |
| Shareholders Equity (Quarterly) | 11.31M |
| Debt to Equity Ratio | 1.052 |
| Current Ratio | 1.770 |
| Net Debt Paydown Yield | -2.86% |